Cargando…
Botulinum toxin‐a treatment reduces human mechanical pain sensitivity and mechanotransduction
The mechanisms underlying the analgesic effects of botulinum toxin serotype A (BoNT‐A) are not well understood. We have tested the hypothesis that BoNT‐A can block nociceptor transduction. Intradermal administration of BoNT‐A to healthy volunteers produced a marked and specific decrease in noxious m...
Autores principales: | Paterson, Kathryn, Lolignier, Stéphane, Wood, John N., McMahon, Stephen B., Bennett, David L. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley-Liss
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112716/ https://www.ncbi.nlm.nih.gov/pubmed/24550077 http://dx.doi.org/10.1002/ana.24122 |
Ejemplares similares
-
Botulinum toxin in the management of acquired motor fusion deficiency
por: Murthy, Ramesh, et al.
Publicado: (2009) -
Botulinum toxin treatment for hypersalivation in anti‐NMDA receptor encephalitis
por: Jun, Jin‐Sun, et al.
Publicado: (2017) -
Altered cortical activation from the hand after facial botulinum toxin treatment
por: Haenzi, Sara, et al.
Publicado: (2014) -
Comparison of different antibiotic protocols for asymptomatic bacteriuria in patients with neurogenic bladder treated with botulinum toxin A
por: Paradella, Ana Claudia, et al.
Publicado: (2016) -
Mechanisms of Botulinum Toxin Type A Action on Pain
por: Matak, Ivica, et al.
Publicado: (2019)